Lataa...
Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization
Aim: To evaluate the efficacy of chemoembolization versus radioembolization in reducing lung shunt fraction (LSF) in patients with hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, from March 2012 to January 2021, 457 patients with HCC underwent planning angiography...
Tallennettuna:
| Julkaisussa: | In Vivo |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
International Institute of Anticancer Research
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286473/ https://ncbi.nlm.nih.gov/pubmed/34182510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12504 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|